Jingjiahang Biopharmaceutical
景嘉航
Jingjiahang Biopharmaceutical
Biotech/Healthcare
Founded in May 2024, Jingjiahang is a clinical-stage innovative drug company focused on developing novel targeted radiopharmaceuticals. It has assembled a core team of industry experts and technical leaders with extensive experience in R&D, nonclinical studies, and clinical development.
Latest round: Series A (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-04-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.